Jurnale medicale
Medicina nucleara
Recuperare, medicina fizica si balneologie
Martie

Jurnale medicale Recuperare, medicina fizica si balneologie, Medicina nucleara, Medicina nucleara, Martie

30 Martie 2014 21:00
In a recent issue of the journal, Steinhoff K. et al. (2014) stated that Malviya G. et al. have described different tracer uptake in infected joints of the same patient tested with 99mTc-rituximab (anti-CD20-mAb) and 99mTc-adalimumab (anti-TNF-Î?-mAb). This sentence is misleading and requires clarif mai mult
Nuclear Medicine and Biology
30 Martie 2014 21:00
Abstract: Introduction: (â??)-[18F]Flubatine is a PET tracer with high affinity and selectivity for the nicotinic acetylcholine Î?4Î?2 receptor subtype. A clinical trial assessing the availability of this subtype of nAChRs was performed. From a total participant number of 21 Alzheimerâ??s disease (A mai mult
Nuclear Medicine and Biology
30 Martie 2014 21:00
Abstract: Introduction: A radioligand for measuring the density of corticotropin-releasing factor subtype-1 receptors (CRF1 receptors) in living animal and human brain with positron emission tomography (PET) would be a useful tool for neuropsychiatric investigations and the development of drugs inte mai mult
Nuclear Medicine and Biology
30 Martie 2014 21:00
Abstract: Introduction: EphA2, one member of the Eph receptor family, is widely expressed in multiple aggressive cancers. SWL, a small peptide identified by phage display, has high binding affinity to EphA2, suggesting that it could be exploited for targeted molecular imaging. Therefore, a novel pep mai mult
Nuclear Medicine and Biology
30 Martie 2014 21:00
Abstract: In an attempt to develop new folate radiotracers with favorable biochemical properties for detecting folate receptor-positive cancers, we have synthesized [124I]-SIB- and [124I]-SIP-folate conjugates using a straightforward and two-step simple reactions. Radiochemical yields for [124I]-SIB mai mult
Nuclear Medicine and Biology
30 Martie 2014 21:00
Abstract: Introduction: The gastrin-releasing peptide receptor (GRPR) was shown to be expressed with high density on several types of cancers. Radiolabeled peptides for imaging and targeted radionuclide therapy have been developed. In this study, we evaluated the potential of statine-based bombesin mai mult
Nuclear Medicine and Biology
30 Martie 2014 21:00
Abstract: Introduction: Insulinoma is the most common form of pancreatic endocrine tumors responsible for hyperinsulinism in adults. These tumors overexpress glucagon like peptide-1 (GLP-1) receptor, and biologically stable GLP-1 analogs have therefore been proposed as potential imaging agents. Here mai mult
Nuclear Medicine and Biology
30 Martie 2014 21:00
Abstract: Introduction: The urokinase plasminogen activator (uPA) system is a proteolytic cascade involved in tumor invasion and metastasis. uPA and its inhibitor PAI-1 are described as biomarkers for breast cancer with the highest level of evidence. The present study describes the synthesis and fir mai mult
Nuclear Medicine and Biology
30 Martie 2014 21:00
30 Martie 2014 21:00
27 Martie 2014 22:00
27 Martie 2014 22:00
27 Martie 2014 22:00
27 Martie 2014 22:00
27 Martie 2014 22:00
27 Martie 2014 22:00
25 Martie 2014 22:00
25 Martie 2014 22:00
20 Martie 2014 22:00
20 Martie 2014 22:00
20 Martie 2014 22:00
20 Martie 2014 22:00
20 Martie 2014 22:00
17 Martie 2014 22:00
17 Martie 2014 22:00
14 Martie 2014 22:00
12 Martie 2014 22:00
12 Martie 2014 22:00
12 Martie 2014 22:00
Abstract: [18F]FMISO is the most widely validated PET radiotracer for imaging hypoxic tissue. However, as a result of the pharmacokinetics of [18F]FMISO a 2h wait between tracer administration and patient scanning is required for optimal image acquisition. In order to develop hypoxia imaging agents mai mult
Nuclear Medicine and Biology
10 Martie 2014 22:00
.
1 - 30 din 62